Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medipal Holdings's quarterly finished goods
increased
from Sep. 2025 (円190,503 Mil) to Dec. 2025 (円219,454 Mil) but then
declined
from Dec. 2025 (円219,454 Mil) to Mar. 2026 (円190,396 Mil).
Medipal Holdings's annual finished goods
increased
from Mar. 2024 (円172,030 Mil) to Mar. 2025 (円178,100 Mil) and
increased
from Mar. 2025 (円178,100 Mil) to Mar. 2026 (円190,396 Mil).
Medipal Holdings Inventories, Finished Goods Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Inventories, Finished Goods can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Inventories, Finished Goods of 円190,396 Mil mean?
Medipal Holdings (TSE:7459) has a Inventories, Finished Goods of 円190,396 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Medipal Holdings and its competitors.
Is Medipal Holdings' Inventories, Finished Goods too high?
Medipal Holdings' current Inventories, Finished Goods is 円190,396 Mil. Overall, Medipal Holdings has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Inventories, Finished Goods compare to MCK and CAH?
Medipal Holdings' Inventories, Finished Goods of 円190,396 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Distribution company?
A good Inventories, Finished Goods depends on the Medical Distribution industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Medipal Holdings and its competitors. Medipal Holdings's current Inventories, Finished Goods is 円190,396 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (TSE:7459) is currently considered Fairly Valued. The stock's GF Value™ is 円2,734.96, compared to a current price of 円2,876.50 — trading 5.2% above its estimated fair value. The current Inventories, Finished Goods is 円190,396 Mil. Medipal Holdings' overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Medipal Holdings (TSE:7459), the current Inventories, Finished Goods is 円190,396 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (TSE:7459) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued.
The current stock price of 円2,876.50 is trading 5.2% above its estimated GF Value™ of 円2,734.96.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for TSE:7459:
Inventories, Finished Goods: 円190,396 Mil
GF Value™: 円2,734.96 vs. price of 円2,876.50 (5.2% above fair value)
No single metric tells the full story. See the TSE:7459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
82GF Score
Get the complete analysis for TSE:7459
Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7459 has been successfully added to your 
